(Q53475522)

14 May 2018

title

Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. (English)

1 reference

14 May 2018

0 references

3

1 reference

14 May 2018

author name string

Spijkerman AM

1

1 reference

14 May 2018

Gall MA

2

1 reference

14 May 2018

Twisk JW

4

1 reference

14 May 2018

Lauritzen E

5

1 reference

14 May 2018

Lund-Andersen H

6

1 reference

14 May 2018

Emeis J

7

1 reference

14 May 2018

Parving HH

8

1 reference

14 May 2018

Stehouwer CD

9

1 reference

14 May 2018

publication date

25 June 2007

1 reference

14 May 2018

published in

Diabetic Medicine

1 reference

14 May 2018

volume

24

1 reference

14 May 2018

issue

9

1 reference

14 May 2018

page(s)

969-976

1 reference

14 May 2018

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

The renin-angiotensin-aldosterone system and the eye in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Is diabetic retinopathy an inflammatory disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Longitudinal data analysis for discrete and continuous outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Different statistical models to analyze epidemiological observational longitudinal data: an example from the Amsterdam Growth and Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

von Willebrand factor and early diabetic retinopathy: no evidence for a relationship in patients with type 1 (insulin-dependent) diabetes mellitus and normal urinary albumin excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

Adhesion molecules and their role in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2007.02217.X

10.1111/J.1464-5491.2007.02217.X

21 January 2018

Identifiers

DOI

1 reference

14 May 2018

1 reference

14 May 2018